New directions in the treatment of heart failure: Targeting free fatty acid oxidation

Gabriele Fragasso, Roberto Spoladore, Giorgio Bassanelli, Amarild Cuko, Chiara Montano, Anna Salerno, Alberto Margonato

Research output: Contribution to journalArticle

Abstract

The possibility of modifying cardiac metabolism by switching the fuel used by the myocardium could become increasingly important. Inhibitors of free fatty acid (FFA) oxidation could have an important role in therapeutic strategy for patients with heart failure, and shifting the energy substrate preference away from FFA metabolism and toward glucose metabolism may be an effective adjunctive treatment. Additionally, abnormalities of glucose homeostasis in patients with heart failure contribute to the progression of the primary disease. If not adequately treated, these abnormalities can contribute to the occurrence of complications, including severe left ventricular dysfunction. Apart from meticulous metabolic control of frank diabetes, special attention should be paid to insulin resistance, a distinct clinical entity. The observed combined beneficial effects of FFA inhibitors on left ventricular function and glucose metabolism represent an additional advantage of these drugs, especially when abnormalities of myocardial and glucose metabolism coexist.

Original languageEnglish
Pages (from-to)236-242
Number of pages7
JournalCurrent Heart Failure Reports
Volume4
Issue number4
DOIs
Publication statusPublished - Dec 2007

Fingerprint

Treatment Failure
Nonesterified Fatty Acids
Heart Failure
Glucose
Left Ventricular Dysfunction
Left Ventricular Function
Disease Progression
Insulin Resistance
Myocardium
Homeostasis
Direction compound
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Emergency Medicine
  • Physiology (medical)

Cite this

New directions in the treatment of heart failure : Targeting free fatty acid oxidation. / Fragasso, Gabriele; Spoladore, Roberto; Bassanelli, Giorgio; Cuko, Amarild; Montano, Chiara; Salerno, Anna; Margonato, Alberto.

In: Current Heart Failure Reports, Vol. 4, No. 4, 12.2007, p. 236-242.

Research output: Contribution to journalArticle

Fragasso, Gabriele ; Spoladore, Roberto ; Bassanelli, Giorgio ; Cuko, Amarild ; Montano, Chiara ; Salerno, Anna ; Margonato, Alberto. / New directions in the treatment of heart failure : Targeting free fatty acid oxidation. In: Current Heart Failure Reports. 2007 ; Vol. 4, No. 4. pp. 236-242.
@article{5e0c2679fe5d424d9f709a06310b16d5,
title = "New directions in the treatment of heart failure: Targeting free fatty acid oxidation",
abstract = "The possibility of modifying cardiac metabolism by switching the fuel used by the myocardium could become increasingly important. Inhibitors of free fatty acid (FFA) oxidation could have an important role in therapeutic strategy for patients with heart failure, and shifting the energy substrate preference away from FFA metabolism and toward glucose metabolism may be an effective adjunctive treatment. Additionally, abnormalities of glucose homeostasis in patients with heart failure contribute to the progression of the primary disease. If not adequately treated, these abnormalities can contribute to the occurrence of complications, including severe left ventricular dysfunction. Apart from meticulous metabolic control of frank diabetes, special attention should be paid to insulin resistance, a distinct clinical entity. The observed combined beneficial effects of FFA inhibitors on left ventricular function and glucose metabolism represent an additional advantage of these drugs, especially when abnormalities of myocardial and glucose metabolism coexist.",
author = "Gabriele Fragasso and Roberto Spoladore and Giorgio Bassanelli and Amarild Cuko and Chiara Montano and Anna Salerno and Alberto Margonato",
year = "2007",
month = "12",
doi = "10.1007/s11897-007-0018-1",
language = "English",
volume = "4",
pages = "236--242",
journal = "Current Alzheimer Research",
issn = "1567-2050",
publisher = "Bentham Science Publishers B.V.",
number = "4",

}

TY - JOUR

T1 - New directions in the treatment of heart failure

T2 - Targeting free fatty acid oxidation

AU - Fragasso, Gabriele

AU - Spoladore, Roberto

AU - Bassanelli, Giorgio

AU - Cuko, Amarild

AU - Montano, Chiara

AU - Salerno, Anna

AU - Margonato, Alberto

PY - 2007/12

Y1 - 2007/12

N2 - The possibility of modifying cardiac metabolism by switching the fuel used by the myocardium could become increasingly important. Inhibitors of free fatty acid (FFA) oxidation could have an important role in therapeutic strategy for patients with heart failure, and shifting the energy substrate preference away from FFA metabolism and toward glucose metabolism may be an effective adjunctive treatment. Additionally, abnormalities of glucose homeostasis in patients with heart failure contribute to the progression of the primary disease. If not adequately treated, these abnormalities can contribute to the occurrence of complications, including severe left ventricular dysfunction. Apart from meticulous metabolic control of frank diabetes, special attention should be paid to insulin resistance, a distinct clinical entity. The observed combined beneficial effects of FFA inhibitors on left ventricular function and glucose metabolism represent an additional advantage of these drugs, especially when abnormalities of myocardial and glucose metabolism coexist.

AB - The possibility of modifying cardiac metabolism by switching the fuel used by the myocardium could become increasingly important. Inhibitors of free fatty acid (FFA) oxidation could have an important role in therapeutic strategy for patients with heart failure, and shifting the energy substrate preference away from FFA metabolism and toward glucose metabolism may be an effective adjunctive treatment. Additionally, abnormalities of glucose homeostasis in patients with heart failure contribute to the progression of the primary disease. If not adequately treated, these abnormalities can contribute to the occurrence of complications, including severe left ventricular dysfunction. Apart from meticulous metabolic control of frank diabetes, special attention should be paid to insulin resistance, a distinct clinical entity. The observed combined beneficial effects of FFA inhibitors on left ventricular function and glucose metabolism represent an additional advantage of these drugs, especially when abnormalities of myocardial and glucose metabolism coexist.

UR - http://www.scopus.com/inward/record.url?scp=38049003591&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38049003591&partnerID=8YFLogxK

U2 - 10.1007/s11897-007-0018-1

DO - 10.1007/s11897-007-0018-1

M3 - Article

C2 - 18221621

AN - SCOPUS:38049003591

VL - 4

SP - 236

EP - 242

JO - Current Alzheimer Research

JF - Current Alzheimer Research

SN - 1567-2050

IS - 4

ER -